Welcome to our dedicated page for PZN news (Ticker: PZN), a resource for investors and traders seeking the latest updates and insights on PZN stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PZN's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PZN's position in the market.
Pzena Investment Management reported preliminary assets under management (AUM) of $53.1 billion as of June 30, 2021, a slight decrease from $53.6 billion in May 2021. Year-over-year, AUM has increased significantly from $31.5 billion in June 2020. For the second quarter, they recorded inflows of $4.0 billion, with total appreciation of $1.7 billion. The firm’s separately managed accounts and sub-advised accounts showed mixed results, with separately managed accounts decreasing slightly while sub-advised accounts grew.
Pzena Investment Management, as of May 31, 2021, reported total assets under management (AUM) of $53.6 billion, reflecting a significant increase from $50.3 billion in April 2021 and $30.8 billion in May 2020. The growth was primarily driven by separately managed accounts, which rose to $20.6 billion, and sub-advised accounts, which reached $30.0 billion. Year-over-year, the U.S. Value Strategies segment also showed strong performance, with total assets growing to $18.2 billion.
Pzena Investment Management reported its preliminary assets under management (AUM) as of April 30, 2021, totaling $50.3 billion, a notable increase from $30.1 billion in April 2020 and $49.2 billion in March 2021. The rise was driven by growth in sub-advised accounts ($27.7 billion) and separately managed accounts ($19.7 billion). All investment strategies, including U.S. Value Strategies and Global & Non-U.S. Value Strategies, showed increases compared to previous months, indicating a robust recovery and investor confidence.
Pzena Investment Management reported a Q1 2021 diluted EPS of $0.24, with total revenue rising 32% year-over-year to $45.9 million. Assets under management reached $49.2 billion by the end of the quarter.
The board approved a quarterly dividend of $0.03 per share, reflecting the company's commitment to returning value to shareholders. Despite the absence of performance fees in Q1 2021, average assets under management increased by 20.4% compared to Q4 2020.
Pzena Investment Management (NYSE: PZN) will host a conference call to discuss its financial results and outlook on April 21, 2021, at 10:00 a.m. ET. The call will be accessible to the public, allowing investors to listen to the company's insights on performance and future strategies.
Webcast access is available on the company's Investor Relations page, while telephone participants can dial specific numbers based on their location. A replay of the call will be offered until May 5, 2021.
Pzena Investment Management reported a significant increase in its assets under management (AUM) as of March 31, 2021, totaling $49.2 billion, up from $46.4 billion in February 2021 and $26.8 billion a year earlier. This growth was largely driven by strong inflows in separately managed accounts, reaching $19.4 billion, and sub-advised accounts, which increased to $26.9 billion. The firm also reported positive investment performance with a quarter-over-quarter appreciation of $6.1 billion in total market value.
Pzena Investment Management, Inc. (NYSE: PZN) reported an increase in its assets under management (AUM) for month-end February 2021, totaling $46.4 billion, up from $42.8 billion in January 2021 and $34.8 billion a year ago. Separately Managed Accounts reached $18.3 billion, while Sub-Advised Accounts rose to $25.3 billion. Pzena Funds increased to $2.8 billion. Notably, U.S. Value Strategies accounted for $16.2 billion, and Global & Non-U.S. Value Strategies contributed $30.2 billion to the total AUM.
Pzena Investment Management reported its preliminary assets under management (AUM) for January 2021 at $42.8 billion, a decrease from $43.3 billion in December 2020 and an increase from $39.0 billion in January 2020. Separately Managed Accounts decreased to $17.0 billion from $17.3 billion last month, while Sub-Advised Accounts remained stable at $23.1 billion. In terms of investment strategies, U.S. Value Strategies dropped to $14.6 billion, while Global & Non-U.S. Value Strategies slightly decreased to $28.2 billion. Overall, the report highlights a mixed performance in AUM.
Pzena Investment Management (NYSE: PZN) will hold a conference call on February 3, 2021, at 10:00 a.m. ET to discuss its financial results and outlook. The call is open to the public, and interested participants can access the webcast via the Investor Relations section of the company's website. The teleconference will provide dial-in options for U.S., Canada, and international callers. A replay of the call will be available until February 17, 2021.
Pzena Investment Management reported preliminary assets under management (AUM) of $43.3 billion as of December 31, 2020, showing an increase from $40.7 billion in November 2020. This growth was driven primarily by an uptick in separately managed accounts, which rose to $17.3 billion from $16.0 billion the previous month.
Fourth-quarter inflows amounted to $1.8 billion, while depreciation and outflows totaled $2.1 billion, leading to a net inflow of $10.3 billion in market appreciation, marking a solid performance.
FAQ
What is the market cap of PZN (PZN)?
